2024-04-02 02:17:00 ET
Summary
- Gilead Sciences is a potential buy due to its attractive valuation, potential for capital gains, and transformative acquisitions.
- Gilead shares have pulled back from recent highs, offering an opportunity to buy a leading company in the sector with a 4.2% yield and low P/E ratio.
- Goldman Sachs BDC is a business development company with a high yield of 12% and significant diversification, making it a compelling investment option.
April is the start of a new month and more importantly a new quarter. Every quarter I like to review strategy and performance in my portfolio and I also like to research and find new stocks to buy that could drive portfolio gains for the rest of the year....
Read the full article on Seeking Alpha
For further details see:
My April Dividend Stock Buys With Yields Up To 12%